Aasiya Matin

417 total citations
18 papers, 170 citations indexed

About

Aasiya Matin is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Aasiya Matin has authored 18 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Oncology and 5 papers in Genetics. Recurrent topics in Aasiya Matin's work include Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Aasiya Matin is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Aasiya Matin collaborates with scholars based in United States, India and Germany. Aasiya Matin's co-authors include Meera Mohan, Faith E. Davies, Vivek Nangia, Jost B. Jonas, Prashant Joshi, Pankaj Mathur, Smriti Sharma, Senu Apewokin, Carolina Schinke and Sharmilan Thanendrarajan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Antimicrobial Agents.

In The Last Decade

Aasiya Matin

14 papers receiving 164 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aasiya Matin United States 5 62 42 32 31 22 18 170
Amy Wang United States 8 111 1.8× 22 0.5× 19 0.6× 17 0.5× 40 1.8× 14 239
Ali S. Alshanqeeti Saudi Arabia 6 67 1.1× 48 1.1× 9 0.3× 17 0.5× 20 0.9× 11 152
C. Cerquaglia Italy 6 231 3.7× 27 0.6× 11 0.3× 16 0.5× 39 1.8× 10 334
Rachel Petermann France 8 31 0.5× 126 3.0× 25 0.8× 9 0.3× 20 0.9× 25 258
Mingqing Song United States 9 62 1.0× 16 0.4× 16 0.5× 42 1.4× 84 3.8× 19 358
Yulan Ye China 7 132 2.1× 5 0.1× 17 0.5× 40 1.3× 92 4.2× 13 320
Jakub Radocha Czechia 10 114 1.8× 151 3.6× 5 0.2× 124 4.0× 37 1.7× 57 287
Yusuf Usta Türkiye 9 68 1.1× 9 0.2× 24 0.8× 12 0.4× 46 2.1× 25 263
Zixi Hong China 6 94 1.5× 22 0.5× 10 0.3× 79 2.5× 17 0.8× 7 336
Hiroya Takeoka Japan 8 68 1.1× 13 0.3× 14 0.4× 18 0.6× 12 0.5× 28 193

Countries citing papers authored by Aasiya Matin

Since Specialization
Citations

This map shows the geographic impact of Aasiya Matin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aasiya Matin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aasiya Matin more than expected).

Fields of papers citing papers by Aasiya Matin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aasiya Matin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aasiya Matin. The network helps show where Aasiya Matin may publish in the future.

Co-authorship network of co-authors of Aasiya Matin

This figure shows the co-authorship network connecting the top 25 collaborators of Aasiya Matin. A scholar is included among the top collaborators of Aasiya Matin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aasiya Matin. Aasiya Matin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sridharan, Meera, Ronald S. Go, Ann M. Moyer, et al.. (2025). Clinical Outcomes and Treatment Strategies of Adult Transplant‐Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High‐Risk Criteria. American Journal of Hematology. 100(5). 830–839. 3 indexed citations
2.
Greipp, Patricia T., Dragan Jevremović, James M. Foran, et al.. (2025). Clinical characteristics and prognostic significance of co-mutated SETBP1/GATA2 myeloid neoplasms. Leukemia Research. 155. 107734–107734.
3.
Johnson, Isla McKerrow, Kristen McCullough, Aref Al‐Kali, et al.. (2025). Predictors of post-transplant survival in patients with newly diagnosed acute myeloid leukemia receiving frontline venetoclax and hypomethylating agents.. Journal of Clinical Oncology. 43(16_suppl). 1 indexed citations
4.
Matin, Aasiya, Byron H. Smith, Abhishek A. Mangaonkar, et al.. (2023). Pericardial Effusion as a Purported Manifestation of Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 29(5). 324.e1–324.e6. 3 indexed citations
5.
Tun, Aung M., Yucai Wang, Aasiya Matin, et al.. (2023). Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant. HemaSphere. 7(4). e869–e869. 1 indexed citations
6.
Kim, Seongho, Hyejeong Jang, Aasiya Matin, et al.. (2023). Acute Leukemia and MDS Patients Older Than 70 Years Have Inferior Survival Following Allogeneic Stem Cell Transplant Compared to Those with 60-69 Years of Age. Blood. 142(Supplement 1). 3612–3612. 1 indexed citations
7.
8.
Reshef, Ran, Hyung C. Suh, Monzr M. Al Malki, et al.. (2022). Trial in Progress: A Phase 1 Umbrella Study of TCR-Engineered T Cells That Target HA-1 (TSC-100) and HA-2 (TSC-101) to Treat Residual Leukemia after Hematopoietic Cell Transplantation. Blood. 140(Supplement 1). 7468–7469. 1 indexed citations
9.
Uberti, Joseph P., Voravit Ratanatharathorn, Dipenkumar Modi, et al.. (2022). Does Choice of Salvage Regimen Impact Stem Cell Mobilization in Hodgkin's Lymphoma?. Blood. 140(Supplement 1). 7565–7566.
10.
Matin, Aasiya, et al.. (2020). Clinical and histological response to combination nivolumab and ipilimumab in metastatic renal cell carcinoma. Baylor University Medical Center Proceedings. 33(2). 258–260. 3 indexed citations
11.
Matin, Aasiya, Abhishek A. Mangaonkar, Arushi Khurana, et al.. (2020). Outcomes of Adult Burkitt Lymphoma Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) in CR1 Versus ≥ CR2 - a Single Institution Retrospective Analysis. Biology of Blood and Marrow Transplantation. 26(3). S246–S246.
12.
Mohan, Meera, Aasiya Matin, & Faith E. Davies. (2017). Update on the optimal use of bortezomib in the treatment of multiple myeloma. Cancer Management and Research. Volume 9. 51–63. 46 indexed citations
13.
Matin, Aasiya, Smriti Sharma, Pankaj Mathur, & Senu Apewokin. (2017). Myelosuppression-sparing treatment of central nervous system nocardiosis in a multiple myeloma patient utilizing a tedizolid-based regimen: a case report. International Journal of Antimicrobial Agents. 49(4). 488–492. 24 indexed citations
14.
15.
Mohan, Meera, Amy Buros, Pankaj Mathur, et al.. (2017). Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease. American Journal of Hematology. 92(8). 739–745. 25 indexed citations
16.
Thanendrarajan, Sharmilan, Joshua Epstein, Faith E. Davies, et al.. (2015). Defining the Impact of Tandem Autologous Stem Cell Transplantation in Multiple Myeloma: A Case-Match Analysis in the Total Therapy Trials. Blood. 126(23). 3182–3182.
17.
Papanikolaou, Xenofon, Sarah Waheed, Bart Barlogie, et al.. (2014). Waldenstrom's Macroglobulinemia Associated Bone Disease the UAMS Experience. Blood. 124(21). 2999–2999. 2 indexed citations
18.
Jonas, Jost B., et al.. (2010). Prevalence, Awareness, Control, and Associations of Arterial Hypertension in a Rural Central India Population: The Central India Eye and Medical Study. American Journal of Hypertension. 23(4). 347–350. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy Wang Breakdown of academic impact, for papers by Ali S. Alshanqeeti Breakdown of academic impact, for papers by C. Cerquaglia Breakdown of academic impact, for papers by Rachel Petermann Breakdown of academic impact, for papers by Mingqing Song Breakdown of academic impact, for papers by Yulan Ye Breakdown of academic impact, for papers by Jakub Radocha Breakdown of academic impact, for papers by Yusuf Usta Breakdown of academic impact, for papers by Zixi Hong Breakdown of academic impact, for papers by Hiroya Takeoka
Rankless by CCL
2026